Skip to main content
SpringerLink
Log in

Tramadol Extended-Release Tablets

A Viewpoint by Carolyn J. Sachs

  • Adis Drug Profiles
  • Guest Commentary
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cepeda MS, Camargo F, Zea C, et al. Tramadol for osteoarthritis. Cochrane Database Syst Rev 2006 Jul 19; 3: CD005522

    PubMed  Google Scholar 

  2. Cepeda MS, Africano JM, Polo R, et al. What decline in pain intensity is meaningful to patients with acute pain? Pain 2003; 105(1–2): 151–7

    Article  PubMed  Google Scholar 

  3. Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med 2001; 38(6): 633–8

    Article  PubMed  CAS  Google Scholar 

  4. Bianchi M, Broggini M, Balzarini P, et al. Effects of tramadol on synovial fluid concentrations of substance P and interleukin-6 in patients with knee osteoarthritis: comparison with paracetamol. Int Immunopharmacol 2003; 3(13–14): 1901–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UCLA Emergency Medicine Center, Los Angeles, California, USA

    Carolyn J. Sachs

Authors
  1. Carolyn J. Sachs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sachs, C.J. Tramadol Extended-Release Tablets. Drugs 66, 2028 (2006). https://doi.org/10.2165/00003495-200666150-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-200666150-00016

Search

Navigation